Placebo slurry

DIETARY_SUPPLEMENT2 trials

Sponsors

University of North Carolina, Chapel Hill, Oslo University Hospital

Conditions

Celiac DiseaseEosinophilic EsophagitisFood Intolerance

Phase 4

Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis

CompletedNCT02019758

University of North Carolina, Chapel HillEosinophilic Esophagitis

Start: 2015-01-01End: 2019-04-30Updated: 2020-04-27

Unknown Phase

Immunosafe-CeD: Are Partially Hydrolysed Gluten Harmful to Celiac Disease Patients?

CompletedNCT06151782

Oslo University HospitalCeliac Disease, Food Intolerance

Start: 2024-01-01End: 2025-06-01Updated: 2025-06-29

Related Papers

Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial

UNC Libraries2023-06-28

Rapid Recurrence of Eosinophilic Esophagitis Activity After Successful Treatment in the Observation Phase of a Randomized, Double-Blind, Double-Dummy Trial

UNC Libraries2023-06-28

Dilation Modifies Association Between Symptoms and Esophageal Eosinophilia in Adult Patients With Eosinophilic Esophagitis

The American Journal of Gastroenterology2020-09-2829 citations

Utility of major basic protein, eotaxin-3, and mast cell tryptase staining for prediction of response to topical steroid treatment in eosinophilic esophagitis: analysis of a randomized, double-blind, double dummy clinical trial

Diseases of the Esophagus2020-03-1920 citations

Rapid Recurrence of Eosinophilic Esophagitis Activity After Successful Treatment in the Observation Phase of a Randomized, Double-Blind, Double-Dummy Trial.

2019-09-0658 citations

Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.

2019-03-11129 citations